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ABSTRACT 
Objective: The recent growth of highly resoluted crystallographic structures, together with the continuous improvements of the computing power, 
has established molecular docking as a leading drug design technique. However, the problems concerning the receptor flexibility and the lowered 
ability of docking software to correctly score the occurred interactions in some receptors are still relevant.  
Methods: Recently, several research groups have reported an enhancement in enrichment values when ensemble docking has been applied. 
Therefore, we utilized the latest technique for a dataset of Monoamine Oxidase–B (MAO-B) inhibitors. The docking program GOLD 5.3 was used in 
our study. Several docking parameters (grid space, scoring functions and ligand flexibility) were altered in order to achieve the optimal docking 
protocol.  
Results: The results of 200 000+docking simulations are represented in a modest table. The ensembled simulations demonstrated low ability of the 
docking software to correctly score the actives seeded in the dataset. However, the superimposed complex-1S3B-1OJA-1OJC, achieved a moderate 
enrichment value equaled to 9. No significant improvements were noted when five complexed receptors were employed.  
Conclusion: As a conclusion, it should be noted that in some cases the ensemble docking enhanced the database enrichments, however overall the 
value is not suitable for future virtual screening. Further investigations in that area should be considered. 
Keywords: Molecular docking, MAO-B, Ensemble docking, Enrichment factor 
© 2021 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (https://creativecommons.org/licenses/by/4.0/) 
DOI: https://dx.doi.org/10.22159/ijpps.2021v13i8.41956. Journal homepage: https://innovareacademics.in/journals/index.php/ijpps.  
 
INTRODUCTION 
Molecular docking is the most common structure-based technique 
utilized for the virtual design and development of novel molecules. 
In general, it observes the interactions between a ligand and a 
receptor applying searching and scoring algorithms [1]. The recent 
growth of highly resoluted crystallographic structures, together with 
the enhanced computer power, established molecular docking as a 
leading drug design technique [2]. However, few downsides such as 
receptor flexibility [3] and the inability of the docking softwares to 
correctly score the occurring bonds [4] are still relevant. 
The problem with the receptor flexibility has been presented as hard 
to deal with, considering the exponential growth of computational 
time [5]. The ensemble docking (ED) somewhat charges that issue, 
since it applies several different conformations of the receptor 
during the docking simulations [6]. The technique has demonstrated 
promising results viewed from the papers reporting high 
enrichments when ED has been applied [7-9]. However, the 
inducement of ensembles cannot always enhance the enrichment 
values as reported by Rao et al. [10]. 
Binda et al. were the first to report the crystallographic structure of 
MAO-B (fig. 1) [11]. The paper has identified three functional 
domains–Entrance cavity, substrate cavity and aromatic cage, of 
which the substrate cavity comprises the biggest volume. The 
authors also described a loop of four amino acids, which separates 
the entrance from the substrate cavity. Moreover, the amino residue 
Ile199 has been found to operate in two different states–opened and 
closed [12, 13]. The aromatic cage was built of (Flavin Adenine 
Dinucleotide) FAD and two tyrosine amino residues–Tyr398 and 
Tyr435 [14]. Numerous papers have described the effects of the 
aromatic cage towards the stabilization of the ligand-receptor 
complex [15-17]. 
The lack of ensemble docking screenings in the active site of the 
crystallographic structure of MAO-B, together with the prominent 
reports about improved enrichments after ensemble docking 
simulations, have encouraged our research group to investigate the 
role of the latest technique in the virtual enrichments of MAO-B. The 
aim of this work was to observe if ED could increase the enrichment 
values in MAO-B crystallographic structures. For that purpose, most 
of the resolved 3D monoamine oxidases were taken from the Protein 
Data Bank (PDB) and ensembled for further docking simulations. 
 
 
Fig. 1: Crystallographic structure of MAO-B with co-crystallized 
ligand (red) [18] 
 
MATERIALS AND METHODS 
Docking program 
For the current study, we utilized (Genetic Optimization for Ligand 
Docking) GOLD 5.3 as a molecular docking program [19]. The 
software operates with four scoring functions–ChemPLP, GoldScore, 
Chemscore and ASP. Gold Score is the first GOLD function and it 
considers Van der Waals clashes as well as calculations of hydrogen 
bonds between the ligands and the receptor. Chemscore is an 
empirical algorithm calibrated from numerous complexes with 
known binding affinities. The knowledge-based function is ASP. The 
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most recent and successful scoring algorithm employed in GOLD is 
ChemPLP, which uses piecewise linear potential to score the 
contacts in the ligand-receptor complex [20]. The program includes 
a wizard with pre-defined docking parameters; however, the binding 
site is user-defined.  
Hardware 
Operating system–Windows 10 Pro; CPU-AMD Ryzen 5 3600 6-core 
3.60 GHz; GPU–GeForce GTX 1060 3 GB; Install memory (RAM)–16 GB 
Pre-docking setup 
All the crystallographic structures of MAO-B with the co-crystallized 
ligands (1OJA, 1OJC, 1S3B, 2BK3, 2C65, 3PO7, 4A7A, 6FVZ, 6FW0, 
6FWC) were downloaded from the protein data bank (PDB) [21]. 
The collected receptors were resolved with resolutions under 2 Å. 
Firstly, from all the MAO-B receptors, monomer B was deleted 
together with the ligands and the co-factor. If a covalent bond 
between FAD N5 and the co-crystallized ligand was present, it was 
removed. Utilizing the GOLD setup wizard, we added hydrogen 
bonds, removed all water molecules and extracted the co-
crystallized ligands. Thereafter, we superimposed the MAO-B 
protein structures. The grid space was firstly altered between 6, 8 
and 10 Å and it was centered on FAD’s N5 atom. The search 
efficiency was switched to “virtual screening” (30%) due to the time-
demanding simulations of the “very flexible (200%)” GOLD docking 
option. The ligand flexibility was also modified between fixed and 
free rotatable bonds. 
Decoys 
The benchmarking set of active compounds and decoys was taken 
from the (Directory of Useful Decoys-Enhanced) DUD-E [22]. It 
contains more than 100 crystallographic proteins with the 
corresponding active and inactive (decoy) molecules. The decoys are 
classified as similar to the active compounds, but with no activity 
towards the observed receptor. No preliminary energy 
minimizations of the receptors and the ligands were performed. It 
should be taken into account that the decoys are not experimentally 
tested. They are compounds with the same physical properties 
however, they could contain some kind of activity towards the 
receptors and should not be considered as completely not active. 
Docking accuracy 
Initial re-docking procedures were carried out applying the default 
GOLD 5.3 settings. The (root mean square diameter) RMSD values of 
the original conformation of the co-crystallized ligand and the 
solutions obtained with the software were examined with Hermes. 
The enrichment factor (EF) represents the quantification of the 
reliability of a docking program. We have calculated both the 
modified enrichment factor (EF`) [7] and the classical EF [23]. The 
latter enrichment value does not take into consideration the 
rankings of the seeded actives, while EF` provides higher values 
when the active compounds are located in top-ranked positions. The 




sampled are the active ligands located in the chosen 
percentage of the dataset. HITStotal  is the sum of all actives seeded in 
the decoys. Ntotal is the number of the whole dataset (7031), while 
Nsampled 
EF`(N) = (50%/APR
is the chosen part of the dataset (in our case 100). 
sampled) x (Hitssampeld/Hitstotal
Where N is the percent of the active compounds set; ARP stands for 
“average percentile rank’’ of Hits
), 
total . In this study we calculated the 
EF` value of 6% of the seeded active compounds, therefore the 
Hitssampeld corresponds to 10; Hitstotal 
RESULTS 
equals 6931. The maximum 
number of EF`(6) would be 37.6, considering the fact the top 10 
rankings were occupied from 10 seeded actives. 
Self-docking 
We started our study with the pre-docking operations, which are 
described in the materials and methods section of this paper. We 
proceed with self-docking simulations in order to evaluate the ability 
of GOLD 5.3 to correctly position and score the removed co-
crystallized ligands. In all examined cases the RMSD values were under 
2 Å, which clearly demonstrates the effectiveness of the program to 
recreate the original pose of the ligands. The downloaded receptors 
were with a chemical diverse set of co-crystallized ligands so that 
different conformers of the active site residues are present.  
Ensemble docking 
Ensembles of three and five receptors were generated and applied 
for the docking of 6931 decoys and 169 active MAO-B inhibitors. We 
utilized the classical enrichment factor, as well as a modified version 
of it, which considers the rankings of the ligands. Exhaustive details 
of both were provided in the “materials and methods” section. 
All the PDB codes of the receptors, together with the optimal scoring 
functions, size of the binding gauge, EF and EF`(6) are given in table 
1. From the observed cases, ChemPLP showed the best results. 
Moreover, it was the fastest scoring function. For the first ensemble 
complex, we altered 4 different sizes of the binding gorge in order to 
find the optimal one. Increasing the cavity volume achieved slightly 
better enrichments, however, the running time was significantly 
increased. Considering the latter observation, we employed 6 Å for 
the rest of the complexes. 
  
Table 1: Calculated enrichments of 9 receptor complexes through ensemble docking. The highest enrichment value was achieved by the 
1S3B-1OJA-1OJC comp superimposed lex 
Receptor/Ensemble Scoring 
algorithm 
Size of the 
binding pocket 
EF EF`(6) 
Flexible ligands Rigid ligands Flexible ligands Rigid ligands 
3PO7-6FW0-6FWC ChemPLP 6 Å 4.17 5.8 4.19 8.13 
8 Å 4.17 5.8 4.11 8.04 
10 Å 4.58 6.25 4.25 8.17 
2BK3-2C65-4A7A ChemPLP 6 Å 5 5 5.9 5.72 
4A7A-6FW0-6FVZ ChemPLP 6 Å 4.58 4.58 4.65 4.72 
1S3B-1OJA-1OJC ChemPLP 6 Å 7.25 6.25 9 8.5 
1S3B-3PO7-4A7A-6FVZ-6FW0 ChemPLP 6 Å 5.42 6.25 5.5 7.9 
10JA-2BK3-2C65-4A7A-6FWC ChemPLP 6 Å 5.42 5.42 3.99 6.4 
1S3B-2XFN-3PO7-6FW0-
6FWC 
ChemPLP 6 Å 4.17 5.42 3.8 5.2 
1S3B-1OJA-1OJC-4A7A-6FWO ChemPLP 6 Å 5.42 4.50 5.06 4.32 
1S3B-1OJA-1OJC-2C65-6FWC ChemPLP 6 Å 5 5.8 5 7.43 
 
Initially, we docked the seeded active molecules and the decoys into 
the ensemble complex of 3PO7, 6FW0 and 6FWC receptors. As 
shown above, when set to 6 and 8 Å, the docking software was able 
to correctly predict 10 active molecules situated in the top 100 
solutions. Interestingly, when we fixed the rotatable bonds of the 
ligands, four additional active ligands were located in the rankings, 
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thus the enrichment factors were enhanced. Furthermore, the 
seeded compounds were with higher ranks demonstrated by the 
increased value of EF`(6).  
The next ensemble complex-2BK3-2C65-4A7A, revealed a slightly 
higher enrichment value. Here 12 of the active ligands were located in 
the top 100 solutions. The rigid docking did not demonstrate better 
enrichment in that case. We followed up with the docking simulations 
of a 4A7A-6FW0-6FVZ ensemble. Compared to the previous case, the 
enrichment factor was lowered. Moreover, the rigid docking in this 
simulation showed no improvements in EF value. Higher enrichment 
was observed when we superimposed 1S3B with the PDB structures 
1OJA and 1OJC. Here the fully flexible ligands demonstrated better 
enrichment in comparison to fixed rotatable bonds. As shown in table 
1, the classical enrichment factor was calculated to be 7.25. Moreover, 
taking the rankings of the actives into consideration has led to an 
enhanced enrichment value of 9.  
An employment of 5 superimposed MAO-B receptors into the 
docking simulations did not conduct the needed improvements in 
the enrichments coefficients. Primarily, we examined the 
enrichment with flexible ligands in the complexes 1S3B-3PO7-4A7A-
6FVZ-6FW0 and 10JA-2BK3-2C65-4A7A-6FWC. The simulations led 
toa coefficient of 5.25. That corresponds to 13 active molecules 
located in the first 100 solutions. However, the rankings of the 
actives between the two ensemble sets did significantly differ. The 
affirmation of that finding came from the calculation of EF`(6), which 
considers the fitness score scores of the active molecules. The value 
of 1S3B-3PO7-4A7A-6FVZ-6FW0 was calculated to be 5.5 with 
comparison to EF`(6)=3.99 in the 10JA-2BK3-2C65-4A7A-6FWC 
ensemble set. Considering the fact that the highest enrichment was 
obtained when the 1S3B-1OJA-1OJC ensemble was superimposed, 
we obtained two complexes with 5 ensembled receptors, including 
the above sequence. In both cases, unsatisfying results were 
analyzed and no further simulations were conducted. 
DISCUSSION 
Numerous papers have reported improved database enrichments 
when ED was utilized in the docking simulations [7-9, 24] as it 
somewhat deals with the flexibility of the side residues of the 
crystallographic structure. Most of the simulations in our work did 
confirm these reports. An example is the superimposed complex 
1S3B-1OJA-1OJC which achieved a moderate enrichment value. 
Furthermore, the actives in the latter case were situated at the top 
positions, which drastically increased the modified enrichment 
factor (EF`) [7] to 9. 
Considering the recent work of Sheng-You Huang [25], it is evident 
that in some cases the flexible docking does not provide higher 
enrichments compared to rigid simulations. Several of the above-
analyzed ensemble complexes confirmed that statement and better 
MAO-B enrichments were calculated when rigid docking was carried 
out. Interestingly, in some instances, the active ligands were scored 
with drastically higher fitness scores compared to the decoys. This 
confirms that the more flexible docking can still score false positives 
and it should not be considered as a prior to the rigid docking 
technique in all cases. Furthermore, the exponential growth of the 
computational time when high numbers of amino residues are 
flexible [26] put into consideration the applicability of fully flexible 
docking. 
Overall, the ensembled simulations in the MAO-B crystallographic 
receptors demonstrated low ability of the docking software GOLD 
5.3 to correctly score the actives seeded in the dataset. The 
enrichment values are not suitable for a future virtual screening and 
further work in that direction should be conducted. 
CONCLUSION 
In this study, more than 210 000 dockings (7060 ligands x 37 
ensembled receptors) were carried out in order to analyze the 
ability of the ensemble docking to correctly score the active seeds in 
a dataset of decoys. We calculated both the standard enrichment 
(EF) and a modified enrichment factor (EF`) which takes into 
account the placement of the active ligands between the decoys. As 
conclusion, it should be noted that in some cases the ensemble 
docking increased the calculated enrichments, however, as a whole 
the value is not suitable for future virtual screening. Further 
investigations in that area should be considered. 
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